Matthew Taylor, an analyst from Jefferies, reiterated the Buy rating on Stryker (SYK – Research Report). The associated price target remains the same with $465.00.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Matthew Taylor has given his Buy rating due to a combination of factors that highlight Stryker’s strong financial performance and strategic positioning. The company reported impressive first-quarter results with revenues and earnings per share surpassing consensus estimates, driven by robust organic growth across its divisions. This performance was supported by strong commercial execution and a promising pipeline, which positions Stryker well for future growth.
Additionally, Stryker’s management has demonstrated effective cost control measures and strategic initiatives to mitigate tariff impacts, such as leveraging its manufacturing footprint and optimizing its network. The company’s ability to offset tariff headwinds while maintaining operational excellence further underscores its resilience and potential for continued success. These factors collectively contribute to Taylor’s optimistic outlook and Buy rating for Stryker’s stock.
In another report released today, BTIG also maintained a Buy rating on the stock with a $403.00 price target.
SYK’s price has also changed slightly for the past six months – from $367.150 to $373.990, which is a 1.86% increase.